Thousands of Xarelto Bleeding Lawsuit Filings Allege They Developed Blood Clots, Hemorrhaging, GastroIntestinal Bleeds And Other Bleeding Events.
As Xarelto bleeding lawsuits mount into the thousands, the first federal Xarelto bellwether trial is scheduled to begin next week in Lousianna. Xarelto lawsuits allege the blood thinner has bleeding side-effects that include brain bleeds, gastrointestinal bleeding, hemorrhaging and uncontrollable bleeding. The complaints accuse Bayer HealthCare and Janssen Pharmaceuticals Inc., which makes and markets Xarelto, of failing to disclose that the anticoagulant does not have an approved antidote should significant bleeding occur. (In Re: Xarelto Bleeding Lawsuit Liability Litigation, No. 2592)
“For the first time, a jury will get to hear details of the life-threatening bleeding episodes people suffer after taking the blood thinner,” says Dr. François Blaudeau, attorney and founder of Southern Med Law.
The firm’s Xarelto lawsuit attorneys are strong advocates for patients who believe they have suffered Xarelto side effects. If you or a loved one experienced life-threatening internal bleeding or other complications allegedly associated with Xarelto, please contact Southern Med Law to learn more about your legal rights. To arrange for a free, no-obligation Xarelto lawsuit review, call Southern Med Law today at 205-547-5525 or visit www.southernmedlaw.com for more information and to fill out a contact form. You can also follow us on Twitter and Facebook information on all product liability matter.
The first bellwether trial involves a Louisiana man who was prescribed Xarelto in January 2014 to treat atrial fibrillation. Nearly a month after taking the blood thinner, the plaintiff suffered severe gastrointestinal bleeding, according to the Xarelto complaint. As a result of the bleeding, the plaintiff was hospitalized and had several blood transfusions. (Xarelto Bleeding Lawsuit Case No. 2:14-cv-02720) The Xarelto bleeding lawsuit trial will be held in the Eastern District of Louisiana in New Orleans where a multidistrict litigation (MDL) has been established for federal Xarelto lawsuits. A bellwether case is representative of all pending lawsuits in an MDL since it has the same common issues as other cases. The outcome of bellwether trials help plaintiffs and defendants to predict trends of similar lawsuits scheduled for future trials.
Xarelto (rivaroxaban) is approved by the U.S. Food and Drug Administration (FDA) to treat deep vein thrombosis, pulmonary embolism and atrial fibrillation not caused by a heart valve problem. The Xarelto anticoagulant has been promoted as a new generation blood thinner that is superior to warfarin (Coumadin and Jantoven), however, Xarelto does not have an antidote to reverse the anticoagulant’s effects should bleeding occur. The FDA states that warfarin uses vitamin K as a reversal agent for adverse bleeding episodes.
The MDL to consolidate the Xarelto lawsuits was established in the New Orleans federal court in December 2014. Since then, lawsuits have been filed on behalf of patients alleging Xarelto caused blood clots, severe internal bleeding, hemorrhaging, deep vein thrombosis, pulmonary embolism and other bleeding side-effects. (In Re: Xarelto Bleeding Lawsuit Liability Litigation, No. 2592)
About Southern Med Law And Filing A Xarelto Bleeding Lawsuit
Throughout his career, Dr. Blaudeau has worked hard to develop a strong reputation in healthcare litigation. His first-hand knowledge of medicine has made the Southern Med Law team an aggressive and effective attorney and advocate for those who were harmed due to negligent pharmaceutical companies. If you or a loved one believe they where harmed by Xarelto, please contact Southern Med Law today to learn more about your legal rights. Call today for a free, no obligation Xarelto lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.
Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203